Statistical analysis Categorical variables were reported as percentages and continuous variables as means ± SD. The Pearson χ 2 test was applied to all categorical variables. Normally distributed continuous variables were compared using the t test or analysis of variance. Variables without normal distribution were evaluated using the Mann-Whitney test or the Kruskal-Wallis analysis of variance, as appropriate. The multivariate analyses were performed using the logistic regression analysis as implemented in the STATISTICA 8.0 software (StatSoft Inc., Tulsa, Oklahoma, United States). A 2-tailed P value of less than 0.05 was regarded as indicating statistical significance.
RESULTS Based on the review of hospital records, 1061 patients were invited to a follow-up interview and examination 6 to 18 months after discharge. Data on 562 patients were included in the present analysis (445 patients did not take part in the interview and 54 did not agree to blood collection). A possible selection bias in the formation of the study population was examined by comparing age, sex, risk factors, and the prescription rate of drugs on discharge between the study population and the 499 patients that could not be included in the analysis. The comparison did not reveal any significant differences with respect to the above factors except for age at the time of hospitalization (63.6 ±8.8 years in analyzed patients vs 64.9 ±10.3 years in nonanalyzed patients; P <0.05) and a prescription rate of angiotensin-converting enzyme inhibitors/sartans on discharge (88.0% in analyzed patients vs 83.8% in nonanalyzed patients; P <0.05). We also compared the attendance rates of the index event groups, which showed a slight but significant bias (P <0.05) characterized by a somewhat higher attendance rate in the percutaneous coronary intervention group. The mean time between discharge and the follow-up interview was 1.1 ±0.2 years.
The characteristics of the analyzed groups are presented in TABLE 1. Patients with high LDL cholesterol levels were younger, less well educated, more likely to be smokers, more likely to have high blood pressure, and were more frequently obese. Overall, 83.6% of the patients were taking statins; 2.1%, fibrates; and 0.5%, ezetimibe (TABLE 2) . Among all study participants, 55.5% were taking atorvastatin; 17.4%, simvastatin; and 10.7%, rosuvastatin. A statin at a high dose (≥40 mg of atorvastatin or ≥20 mg of rosuvastatin) was taken by 36.1% of the patients. When 80 mg of simvastatin was also taken into account, the proportion increased to 36.7%.
The variables independently related to statin use are presented in Despite the overwhelming evidence of the benefits of lowering cholesterol levels, especially when using statins, a majority of patients with CAD still have LDL cholesterol levels above the treatment target. [5] [6] [7] [8] [9] [10] Moreover, although high-dose statins should be prescribed to survivors of acute coronary syndromes, most patients take lower doses. 11 Furthermore, several factors influencing the quality of secondary prevention in everyday practice have been identified. 6, 12 Nevertheless, identifying the remaining barriers to effective risk factor control is essential to maximize the benefit of preventive interventions. A number of intervention methods aimed at improving secondary prevention in patients with CAD have been proposed to date. [13] [14] [15] [16] [17] [18] [19] However, in order to achieve the maximum benefit from these interventions, their intensity and complexity should be adjusted according to specific populations or even according to specific patients.
20 Therefore, the aim of our study was to identify factors related to control of LDL cholesterol levels in patients after hospitalization due to CAD.
PATIENTS AND METHODS
The study population and the methods used have been described in earlier reports. 5, 6 A brief description is given below.
Five hospitals serving one city and surrounding districts in southern Poland participated in the survey. The total population in this area is around 1 200 000 inhabitants. In each cardiac department, medical records were reviewed and consecutive patients who had been hospitalized for acute myocardial infarction, unstable angina, percutaneous coronary intervention or were scheduled for coronary artery bypass grafting were retrospectively identified, excluding those who had died during their in-hospital stays. Participants were invited to take part in a followup examination 6 to 18 months after discharge. The interviews were started in July 2011 and finished in May 2013. About 64% of the participants included in the present analysis agreed to have their data and blood samples transferred to the EUROASPIRE IV survey. 7 Data on demographic characteristics, personal history of CAD, smoking status, blood pressure, fasting glucose levels, plasma lipid levels, and prescribed medications were obtained using a standardized data collection form. Patients had their height and weight measured in a standing position without shoes and heavy outer garments, using standard scales with a vertical ruler. The body mass index (BMI) was calculated according to the following formula: BMI = weight For the purposes of the present analysis, we divided the study group according to LDL cholesterol levels (<1.8 mmol/l vs 1.8-3.9 mmol/l vs ≥4.0 mmol/l). lipid -lowering therapy improves clinical outcomes in patients with CAD, 71.9% of study participants had LDL cholesterol levels above the recommended target. The majority of these patients probably did not receive proper evaluation and treatment for dyslipidemia following hospitalization due to CAD. In general, our results showed a considerable potential for a further reduction in cardiovascular risk following hospitalization for CAD through improvement in the management of hypercholesterolemia.
In the previous report, we used data from patients hospitalized due to CAD between 1996 and 1999 to analyze factors related to the use of lipid--lowering drugs 6 to 18 months after hospitalization due to CAD, and we showed that hospitalization in a teaching hospital almost doubled the likelihood of taking a lipid-lowering drug following hospitalization. 20 Our present results suggest that this association has not changed since the end of the 20th century despite a number of educational activities organized for physicians and despite profound changes in the Polish society induced by the collapse of the communist system in 1989 and by entering the European Union in 2004. The Poland's health care system has been in transition for the last 20 years, both in terms of institutional changes and regulations regarding drug registration, prescription, and reimbursement. Importantly, the relative position of primary care physicians and specialists has evolved. In this respect, it is worth noting that the relationship between the use of lipid-lowering drugs and practice setting has not changed significantly. 20 No correlation was observed between a patient's level of education and the probability of having LDL cholesterol levels below 1.8 mmol/l or below 2.5 mmol/l following hospitalization due to CAD among participants of the EUROASPIRE IV survey.
21 Our results are concordant with those reported by Bruthans et al, 21 as duration of education was not related to the probability of appropriate control of cholesterol levels in our study group. However, we were able to show the independent relationship between duration of education and the probability of having very high LDL cholesterol levels (≥4.0 mmol/l).
Professional inactivity was the most important factor related to very high LDL cholesterol levels. This might be due to financial barriers but other factors (eg, a number of comorbidities as well as psychological factors) might be also responsible for this finding. Indeed, patients with high LDL cholesterol levels were not only taking lipid-lowering drugs less frequently compared with patients with lower LDL cholesterol levels, Overall, 28.1% of the patients had target LDL cholesterol levels (<1.8 mmol/l), whereas 71.9%, 38.6%, 24.4%, and 10.3% of the patients had LDL cholesterol levels of 1.8 mmol/l or higher, 2.5 mmol/l or higher, 3.0 mmol/l or higher, and 4.0 mmol/l or higher, respectively. Among participants aged 65 years or younger, 24.7% had LDL cholesterol levels below 1.8 mmol/l, whereas among those older than 65 years, the proportion was 31.5% (P = 0.07). The corresponding proportions were as follows: 30.1% among men vs 24.5% among women (P = 0.16), and 29.7% among patients with at least a secondary school education vs 26.6% in less educated participants (P = 0.42). Similarly, 23.7% of professionally active participants had LDL cholesterol levels below 1.8 mmol/l, in comparison with 29.3% of those who were professionally inactive (P = 0.23). The corresponding proportions were 30.9% among patients with myocardial infarction as an index diagnosis; 26.8% in those with unstable angina, 28.1% in those with percutaneous coronary intervention, and 22.0% in those with coronary artery bypass grafting (P = 0.61).
When we limited the analysis to patients taking a statin, 69.6%, 32.3%, 18.3%, and 7.4% had LDL cholesterol levels of 1.8 mmol/l or higher, 2.5 mmol/l or higher, 3.0 mmol/l or higher, and 4.0 mmol/l or higher, respectively. When we limited the analysis to patients taking a high-dose statin, 62.9%, 29.5%, 19.7%, and 8.9% had LDL cholesterol levels of 1.8 mmol/l or higher, 2.5 mmol/l or higher, 3.0 mmol/l or higher, and 4.0 mmol/l or higher, respectively.
The factors related to the lack of adequate control of cholesterol levels are presented in TABLE 4 (univariate analysis) and in TABLE 5 (multivariate analysis). When we excluded other risk factors (smoking, hypertension, high fasting glucose levels) from the multivariate model, the only variable significantly related to the probability of having uncontrolled LDL cholesterol (≥1.8 mmol/l) was age. Similarly, when we did not include other risk factors into the multivariate model, the following variables were independently related to the probability of having very high LDL cholesterol levels (≥4.0 mmol/l): age (OR, 0.47; 95% CI, 0.33-0.68), duration of education (OR, 0.87; 95% CI, 0.79-0.97), professional activity (OR, 0.22; 95% CI, 0.08-0.64), unstable angina as an index event (OR, 2.53; 95% CI, 1.41-4.54), and participation in cardiac rehabilitation following the index hospitalization (OR, 0.36; 95% CI, 0.16-0.80).
DISCUSSION
The principal finding of this study is that despite overwhelming evidence that probability of having target LDL cholesterol levels. On the other hand, it was independently related to very high LDL cholesterol levels. The long time interval since the last coronary event is usually considered as related to nonoptimal secondary medical prevention. Indeed, but they were also taking antiplatelet drugs and angiotensin-converting enzyme inhibitors/sartans less frequently. In addition, control of hypercholesterolemia was related to high blood pressure and smoking. The participation in a cardiac rehabilitation program was not related to the 
